1. To understand the evolving classification of papillary RCC from the histopathologic and molecular perspective and their clinical significance.
  2. To recognize the low grade and high grade “derivatives” of papillary RCC and their potential impact to management.
  3. To explore the differential diagnoses of “renal cell tumors with papillary architecture” and their prognostic implications.
Session date: 
12/17/2025 - 7:00am to 8:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Gladell Paner, MD